Psychedelic Research

New review of 22 studies suggests psychedelic therapy in hospice can ease depression, anxiety, and the terror of dying — but the data are still whisper-thin.

Imagine stepping into a sensory deprivation tank, and within minutes, your brain waves slow, and your mind enters a deep state of relaxation, comparable…

A viral claim says microdoses of psilocybin reverse obesity and diabetes. Here’s what the actual mouse study found — and the liver mechanism behind it.

The science of psilocybin microdosing unpacked: brain rewiring, mood, focus, and the gap between hype and hard evidence in older adults.

Discover the key difference between meditation and hypnosis, which may suggest a distinct impact on higher-order awareness and brain function

Explore what a meta‐analysis of six trials says about psilocybin therapy for depression—benefits, side‐effects, and the limits of current evidence.

Explore emerging evidence on ibogaine therapy for opioid cravings, PTSD, and depression. Learn about early study outcomes, safety concerns, and limits of the research.

A deep dive into the emerging review on psychedelics for autism—what the data say, why neuroplasticity matters, and the ethical roadblocks ahead.

A 2026 preprint reviews 25 disciplines of altered states, from meditation to psychedelics, and maps the brain mechanisms behind mind‐expanding practices.

Psychedelic therapy may suggest new options for patients with treatment-resistant depression or PTSD, but what does the evidence show about its effectiveness…